E
15.54
0.25 (1.64%)
Penutupan Terdahulu | 15.29 |
Buka | 15.52 |
Jumlah Dagangan | 401,255 |
Purata Dagangan (3B) | 354,532 |
Modal Pasaran | 896,685,952 |
Harga / Pendapatan (P/E TTM) | 12.95 |
Harga / Jualan (P/S) | 1.04 |
Julat 52 Minggu | |
Tarikh Pendapatan | 19 Nov 2024 - 25 Nov 2024 |
Hasil Dividen (DY TTM) | 2.90% |
Margin Keuntungan | 6.23% |
Margin Operasi (TTM) | 29.98% |
EPS Cair (TTM) | 1.34 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -4.80% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -3.30% |
Nisbah Semasa (MRQ) | 2.11 |
Aliran Tunai Operasi (OCF TTM) | 38.70 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 46.59 M |
Pulangan Atas Aset (ROA TTM) | 9.64% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
Stok | Embecta Corp. | Menaik | Menaik |
AISkor Stockmoo
0.8
Konsensus Penganalisis | 3.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | -2.5 |
Osilator Teknikal | 4.0 |
Purata | 0.75 |
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. |
|
Sektor | Healthcare |
Industri | Medical Instruments & Supplies |
Gaya Pelaburan | Small Value |
% Dimiliki oleh Orang Dalam | 0.47% |
% Dimiliki oleh Institusi | 98.23% |
Julat 52 Minggu | ||
Median | 26.00 (67.31%) | |
Jumlah | 1 Beli |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
BTIG | 27 Nov 2024 | 26.00 (67.31%) | Beli | 20.59 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
19 Dec 2024 | Pengumuman | embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference |
26 Nov 2024 | Pengumuman | Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs |
26 Nov 2024 | Pengumuman | embecta Announces Quarterly Cash Dividend |
12 Nov 2024 | Pengumuman | embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results |
07 Nov 2024 | Pengumuman | embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell |
Hasil Dividen (DY TTM) | 2.90% |
Purata Hasil Dividen 2T | 2.28% |
Nisbah Pembayaran | 50.00% |
Jangkaan Pembayaran Dividen Seterusnya | Mar 2025 |
Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
---|---|---|---|
27 Aug 2024 | 09 Aug 2024 | 13 Sep 2024 | 0.15 Tunai |
24 May 2024 | 09 May 2024 | 14 Jun 2024 | 0.15 Tunai |
27 Feb 2024 | 09 Feb 2024 | 15 Mar 2024 | 0.15 Tunai |
01 Dec 2023 | 21 Nov 2023 | 15 Dec 2023 | 0.15 Tunai |
24 Aug 2023 | 08 Aug 2023 | 13 Sep 2023 | 0.15 Tunai |
25 May 2023 | 12 May 2023 | 13 Jun 2023 | 0.15 Tunai |
24 Feb 2023 | 14 Feb 2023 | 13 Mar 2023 | 0.15 Tunai |
29 Dec 2022 | 20 Dec 2022 | 11 Jan 2023 | 0.15 Tunai |
25 Aug 2022 | 12 Aug 2022 | 14 Sep 2022 | 0.15 Tunai |
Hasil Dividen Tahunan
Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
---|---|---|---|
2024 | 0.450 | 3 | 2.90 |
2023 | 0.750 | 5 | 3.96 |
2022 | 0.150 | 1 | 0.59 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2024 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |